Protagonist Therapeutics (PTGX) Amortizatization of Intangibles (2016 - 2026)

Protagonist Therapeutics has reported Amortizatization of Intangibles for 11 years, with the latest figure at $1.0 million in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 55.22% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 37.6% YoY) and the FY2025 annual result came in at $7.2 million, down 18.61% from the prior year.
• Amortizatization of Intangibles retreated to $1.0 million in Q1 2026 per PTGX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $2.8 million in Q3 2024 and troughed at -$358000.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 1100.0% in 2023, then tumbled 55.22% in 2026.
• Over 5 years, Amortizatization of Intangibles stood at $914000.0 in 2022, then jumped by 47.48% to $1.3 million in 2023, then surged by 104.75% to $2.8 million in 2024, then slumped by 51.59% to $1.3 million in 2025, then retreated by 23.28% to $1.0 million in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.0 million, $1.3 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.